Pro-Dex (PDEX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Pro-Dex (PDEX) is Neutral.

The composite score behind that read is +0.08, weighing +0.42 of bullish evidence against -0.28 bearish.

Pro-Dex last closed at $62.49, +0.45% on the session.

Against the IVW growth benchmark the position is -0.35% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

6 graded predictions for PDEX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Pro-Dex in the 62nd percentile on valuation and the 88th percentile on return on equity, where 100 is best.

Pro-Dex is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $201.12M.

StockMap tracks Pro-Dex as the 95th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Pro-Dex ranks 19th of 140 in the group, against a group median of -0.03.